Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

OTC Drugs, Medical Devices and Diagnostics Market to Hit $359.7 Billion by 2029

This image opens in the lightbox

News provided by

BCC Research LLC

24 Apr, 2025, 19:37 GMT

Share this article

Share toX

Share this article

Share toX

"Rising chronic disease burden and increased health awareness are driving significant growth in the global OTC drugs, medical devices and diagnostics market."

BOSTON, April 24, 2025 /PRNewswire/ -- BCC Research reveals in its new report, OTC Drugs, Medical Devices, and Diagnostics: Global Markets, the over-the-counter drugs, medical devices and diagnostics market is estimated to grow to $359.7 billion by 2029 at a compound annual growth rate (CAGR) of 7.4% for the forecast period. The rising prevalence of chronic diseases and heightened health awareness following the COVID-19 pandemic are propelling this global market.

This indepth analysis categorizes OTC products by pharmaceutical drugs, vitamin and mineral supplements and various devices and diagnostics for disease management, including monitoring, therapeutic and diagnostic kits. The market is further segmented by application to include a range of health issues such as respiratory, orthopedic, gastrointestinal, cardiovascular, ENT, skin and sleep disorders, as well as diabetes and obesity.

Covering a wide range of OTC products and applications, the report highlights industry advancements, relevant patents and the regulatory landscape. For instance, companies like Apple and Samsung are acquiring regulatory approvals, which could revolutionize the wearable devices sector and significantly enhance OTC disease monitoring.

Factors Driving the Market:

Chronic diseases and aging population: The rise in chronic disease prevalence and an aging population increase the demand for OTC drugs, medical devices, and diagnostics.

Health awareness: People are more aware of health maintenance and disease prevention, driving demand for OTC products and diagnostics.

Online sales and telehealth: E-commerce and telehealth platforms make healthcare products and services more accessible, boosting market growth.

Request a sample copy of the OTC Drugs, Medical Devices, and Diagnostics: Global Markets report.

Report Synopsis 

Report Metric

Details

Base year considered

2023

Forecast period considered

2024-2029

Base year market size

$236.8 billion

Market size forecast

$359.7 billion

Growth rate

CAGR of 7.4% for the forecast period of 2024-2029

Segments covered

Product, application

Countries/Regions Covered

North America, Europe, Asia-Pacific, Rest of the World — including U.S., Canada, Germany, U.K., France, Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, the Netherlands, Sweden, Russia, Lithuania, Latvia, Hungary, Slovakia, China, India, Japan, Australia, South Korea, Singapore, Malaysia, New Zealand, Thailand, the Philippines, Vietnam, Indonesia, South America, the Middle East, and Africa

Market drivers

•         Growing prevalence of chronic diseases and expanding geriatric populations

•         Increasing health awareness

•         Growing online sales channels and telehealth platforms

Industry Facts:

  •  The U.S. FDA approved the Apple Watch's AFib feature in 2024, integrating wearable tech into clinical trials. This development revolutionizes OTC devices by empowering consumers and advancing real-time, noninvasive health monitoring for medical research.
  •  Leading global pharmaceutical companies are spinning off their consumer health businesses. This shift allows them to focus on core biopharma operations, allocate resources more effectively, adopt flexible business models, and better serve customers.
  •  The OTC drugs, medical devices, and diagnostics market is a multibillion-dollar industry. Fragmented with a mix of multinational and smaller companies, each segment has its own unique players.

Emerging Startups

  •  NOWDiagnostics develops and manufactures "Touch to Test" over-the-counter and point-of-care diagnostic tests that deliver results in minutes. The company's patented technology enables accurate onsite immunological assays using a minimal amount of capillary blood or saliva.
  •  Vitable is a health and wellness startup that offers personalized vitamin and customized supplement and vitamin packs tailored to individual needs and delivered directly to customers.
  •  Valencell plans to launch the Fingertip Blood Pressure Monitor, the world's first OTC device to measure blood pressure from the finger without a cuff.

Questions Addressed:

1. What is the projected market size and growth rate of the OTC drugs, medical devices and diagnostics market?

•   The global OTC drugs, medical devices and diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 7.4% to reach $359.7 billion by 2029 from $251.7 billion in 2024.

2. Which segments are covered in the report?

•   The market is segmented based on product, application and region.

3. Which product segment will dominate the market by the end of 2029?

•   The OTC drugs segment will dominate the market by the end of 2029.

4. Which region has the largest market share?

•   North America holds the largest share.

Market Leaders:

  •  Koninklijke Philips N.V.
  •  Masimo
  •  Nestle
  •  Procter & Gamble
  •  Sanofi
  •  Abbott
  •  Bayer
  •  Dsm-firmenich
  •  Haleon Group of Companies
  •  Kenvue

Related Reports:

Nutraceuticals: Global Markets: The report analyzes the market shares of leading companies in the nutraceuticals market. It segments the market by product type into functional beverages, food, and dietary supplements. Applications include sports and energy, weight management, general wellness, heart health, gastrointestinal (GI) and digestive health. Distribution channels are categorized by e-commerce, supermarkets, pharmacies, retail stores, and other distribution channels. Regional estimates cover North America, Europe, Asia-Pacific, and the Rest of the World.

Wearable Medical Devices: Technologies and Global Markets: This research report covers the global market for wearable medical devices, segmented by product, application, and sales channel. It includes an in-depth analysis of market estimations and trends. The market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The report discusses major players, technologies, applications, market dynamics and geographic opportunities and examines analytical frameworks like PESTEL, ESG, regulatory landscape, reimbursement scenario, and competitive analysis to aid strategic planning.

Directly purchase a copy of this report from BCC Research.

For further information or any of these reports or to make a purchase, please contact info@bccresearch.com.    

About BCC Research

BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

Contact Us

Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA

Email: info@bccresearch.com

Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo - https://mma.prnewswire.com/media/2183242/5286130/BCC_Research_Logo.jpg

Modal title

Also from this source

Chemicals for Cosmetics & Toiletries to Reach $35.0 Billion by 2029: Global Market Trends

Chemicals for Cosmetics & Toiletries to Reach $35.0 Billion by 2029: Global Market Trends

According to the latest study from BCC Research, "Global Markets for Chemicals for Cosmetics & Toiletries" is expected to grow from $27.7 billion in...

Single-Cell Genomics and Proteomics: Leading the Future of Biomedical Research

Single-Cell Genomics and Proteomics: Leading the Future of Biomedical Research

According to the latest study from BCC Research, the "Single-Cell Genomics and Proteomics: Emerging Technologies and Markets" is expected to grow...

More Releases From This Source

Explore

Publishing & Information Services

Publishing & Information Services

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.